5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum.

Let's take a closer look at five of this past week's biggest scorchers.

Company

Jan. 6 Weekly Gain My Watchlist
Rare Element Resources (NYSE: REE  ) $5.76 77% Add
Dendreon (Nasdaq: DNDN  ) $12.35 63% Add
BBVA Banco Frances (NYSE: BFR  ) $6.28 29% Add
Zogenix (Nasdaq: ZGNX  ) $2.82 27% Add
Complete Genomics (Nasdaq: GNOM  ) $3.71 27% Add

Source: Barron's.

Rare Element Resources was last week's biggest gainer, bouncing back after tax-loss selling made it one of the prior week's biggest losers. Rare Element took off after posting encouraging news from its Bear Lodge project, forecasting a 38% increase in the project's mineral resources.

Dendreon was one of the market's more volatile stocks in 2011, and it's at least getting 2012 off to a strong start. Dendreon revealed stronger than expected sales of its Provenge cancer drug.

If you think stateside stocks kicked off the new year with a bang, we've got nothing on Argentina. The country's benchmark stock index soared 12.5% on the week, as bargain hunters pounded on Argentine equities. BBVA Banco Frances is one of that country's most prolific banks.

William Blair initiated coverage on Zogenix with an outperform rating last week. The firm's analyst set an initial price target of $6 on the shares. Even after last week's 27% pop, the biotech would still have to more than double from here to hit William Blair's price target.

Finally, we have Complete Genomics on the move. There was no material news on the genetics specialist during the week, but after seeing its stock shed more than 60% of its value in 2011, a healthy bounce in 2012's first week of trading isn't a surprise.

It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.

The Motley Fool owns shares of Dendreon. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1754383, ~/Articles/ArticleHandler.aspx, 9/17/2014 2:05:15 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 17,142.34 10.37 0.06%
S&P 500 2,000.29 1.31 0.07%
NASD 4,554.10 1.34 0.03%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/17/2014 1:43 PM
BFR $12.73 Down -0.41 -3.12%
BBVA Banco Frances… CAPS Rating: **
DNDN $1.48 Up +0.01 +0.68%
Dendreon Corp CAPS Rating: *
GNOM.DL $0.00 Down +0.00 +0.00%
Complete Genomics CAPS Rating: **
ZGNX $1.19 Up +0.03 +2.59%
Zogenix, Inc. CAPS Rating: **

Advertisement